ELI LILLY & Co (LLY)
Data as of , from SEC Form 4 filings.
See up to 3 months of LLY. The 7-day demo opens the 1M and 3M ranges and puts LLY on your watchlist.
Start 7-day demoLatest LLY insider trades
Patrik Jonsson - OfficerOpen-market sale$7.64M- Donald A. Zakrowski - OfficerOpen-market sale$2.37M
About ELI LILLY & Co (LLY)
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
- INDIANAPOLIS, IN
- 50,000
- 1970
- XNYS
LLY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 13,500 | $15.96M |
| Grant or award | 12 | 111.29 | |
| Option exercise | 2 | 1,962 | |
LLY insider transactions (Form 4)
39179 Form 4 filings on record, the earliest from Oct 22, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Juan R. Luciano - Director | Grant or award | Common Stock | 17.3 | $919.90 | $16K | |
 J. Erik Fyrwald - Director | Grant or award | Common Stock | 10.78 footnote F1 | $919.90 | $10K | |
| ||||||
| Ralph Alvarez - Director | Grant or award | Common Stock | 13.5 footnote F1 | $919.90 | $12K | |
| ||||||
 Gabrielle Sulzberger - Director | Grant or award | Common Stock | 5.01 footnote F1 | $989.12 | $5K | |
| ||||||
| Juan R. Luciano - Director | Grant or award | Common Stock | 16.09 footnote F1 | $989.12 | $16K | |
| ||||||
| J. Erik Fyrwald - Director | Grant or award | Common Stock | 10.03 footnote F1 | $989.12 | $10K | |
| ||||||
| Ralph Alvarez - Director | Grant or award | Common Stock | 12.55 footnote F1 | $989.12 | $12K | |
| ||||||
| Eric Dozier - Officer | Gift | Common Stock | 481 | $0.00 | - | |
| Gabrielle Sulzberger - Director | Grant or award | Common Stock | 4.79 footnote F1 | $1,036.05 | $5K | |
| ||||||
| Juan R. Luciano - Director | Grant or award | Common Stock | 15.36 footnote F1 | $1,036.05 | $16K | |
| ||||||
| J. Erik Fyrwald - Director | Grant or award | Common Stock | 9.57 footnote F1 | $1,036.05 | $10K | |
| ||||||
| Ralph Alvarez - Director | Grant or award | Common Stock | 11.99 footnote F1 | $1,036.05 | $12K | |
| ||||||
| Donald A. Zakrowski - Officer | Option exercise | Common Stock | 184 | $0.00 | - | |
| Donald A. Zakrowski - Officer | Tax withholding / forfeiture | Common Stock | 81.55 footnote F1 | $1,040.00 | $85K | |
| Donald A. Zakrowski - Officer | Option exercise | Restricted Stock Unit | 184 | $0.00 | - | |
| ||||||
| Lucas Montarce - Officer | Option exercise | Common Stock | 368 | $0.00 | - | |
| Lucas Montarce - Officer | Tax withholding / forfeiture | Common Stock | 159.73 | $1,040.00 | $166K | |
| Lucas Montarce - Officer | Option exercise | Restricted Stock Unit | 368 | $0.00 | - | |
| Kenneth L. Custer - Officer | Option exercise | Common Stock | 207 | $0.00 | - | |
| Kenneth L. Custer - Officer | Tax withholding / forfeiture | Common Stock | 91.31 | $1,040.00 | $95K | |
| Kenneth L. Custer - Officer | Option exercise | Restricted Stock Unit | 207 | $0.00 | - | |
| Adrienne S. Brown - Officer | Option exercise | Common Stock | 391 | $0.00 | - | |
| Adrienne S. Brown - Officer | Tax withholding / forfeiture | Common Stock | 169.97 | $1,040.00 | $177K | |
| Adrienne S. Brown - Officer | Option exercise | Restricted Stock Unit | 391 | $0.00 | - | |
| Diogo Rau - Officer | Grant or award | Common Stock | 4,599 | $1,044.67 | $4.80M | |
| Donald A. Zakrowski - Officer | Grant or award | Common Stock | 583.78 | $1,044.67 | $610K | |
| Donald A. Zakrowski - Officer | Grant or award | Restricted Stock Unit | 199.47 | $0.00 | - | |
| Ilya Yuffa - Officer | Grant or award | Common Stock | 4,163 | $1,044.67 | $4.35M | |
| Naarden Jacob van - Officer | Grant or award | Common Stock | 4,866 | $1,044.67 | $5.08M | |
| Daniel Skovronsky - Officer | Grant or award | Common Stock | 15,548 | $1,044.67 | $16.24M | |
| David A. Ricks - Officer | Grant or award | Common Stock | 38,914 | $1,044.67 | $40.65M | |
| Diogo Rau - Officer | Grant or award | Common Stock | 4,432 | $1,044.67 | $4.63M | |
| Lucas Montarce - Officer | Grant or award | Common Stock | 1,365 | $1,044.67 | $1.43M | |
| Patrik Jonsson - Officer | Grant or award | Common Stock | 4,818 | $1,044.67 | $5.03M | |
| Edgardo Hernandez - Officer | Grant or award | Common Stock | 4,384 | $1,044.67 | $4.58M | |
| Anat Hakim - Officer | Grant or award | Common Stock | 8,278 | $1,044.67 | $8.65M | |
| Eric Dozier - Officer | Grant or award | Common Stock | 3,512 | $1,044.67 | $3.67M | |
| Kenneth L. Custer - Officer | Grant or award | Common Stock | 659.28 | $1,044.67 | $689K | |
| Adrienne S. Brown - Officer | Grant or award | Common Stock | 1,196 | $1,044.67 | $1.25M | |
Item 2.02, 9.01
Item 8.01, 9.01
Item 5.07
Item 2.02, 9.01
Recent LLY Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| LILLY ENDOWMENT, INC. | Shareholder | 305,000 | $368.67M | View on EDGAR | |
| LILLY ENDOWMENT, INC. | Shareholder | 300,000 |
Stock trades in LLY disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Michael A. RulliRepublican, OH-06 | Purchase |
LLY insider trading FAQ
What is the latest insider trade for LLY?
ELI LILLY & Co (LLY) had 19 insider filings in the last 90 days, with the most recent on 2026-09-22. The full record for LLY runs to 179 Form 4 filings, the earliest from 2024-10-22. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LLY stock?
No insider purchases of LLY were filed in the last 90 days. 9 purchases are on record for this company.
How many insiders are selling LLY stock?
3 insider sales of LLY were filed in the last 90 days, totaling $15.96M.
Where can I see LLY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LLY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Gabrielle Sulzberger view on EDGAR
- - Juan R. Luciano view on EDGAR
- - J. Erik Fyrwald view on EDGAR
- - Ralph Alvarez view on EDGAR
- - Melissa Seymour view on EDGAR
- - Edgardo Hernandez view on EDGAR
- - Eric Dozier view on EDGAR
- - Gabrielle Sulzberger view on EDGAR
- - Juan R. Luciano view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where LLY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LLY with a 7-day demo
- LLY on your watchlist
- Every LLY Form 4 filing on record
- Up to 3 months of LLY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
